31 related articles for article (PubMed ID: 14506156)
1. The Role of Androgen Receptor Signaling in Ovarian Cancer.
Mizushima T; Miyamoto H
Cells; 2019 Feb; 8(2):. PubMed ID: 30791431
[TBL] [Abstract][Full Text] [Related]
2. Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer.
Pedernera E; Gómora MJ; Morales-Vásquez F; Pérez-Montiel D; Mendez C
J Ovarian Res; 2019 Feb; 12(1):15. PubMed ID: 30736825
[TBL] [Abstract][Full Text] [Related]
3. The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications.
Zhu H; Zhu X; Zheng L; Hu X; Sun L; Zhu X
Oncotarget; 2017 Apr; 8(17):29395-29405. PubMed ID: 27741511
[TBL] [Abstract][Full Text] [Related]
4. The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer.
Meng X; Lu P; Chu Z; Fan Q
Oncotarget; 2016 Jan; 7(2):2105-12. PubMed ID: 26556855
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the role of antiandrogen strategies in ovarian cancer.
Papadatos-Pastos D; Dedes KJ; de Bono JS; Kaye SB
Oncologist; 2011; 16(10):1413-21. PubMed ID: 21948654
[TBL] [Abstract][Full Text] [Related]
6. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.
Levine DA; Boyd J
Cancer Res; 2001 Feb; 61(3):908-11. PubMed ID: 11221880
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in ovarian cancer.
Friedlander ML
Semin Oncol; 1998 Jun; 25(3):305-14. PubMed ID: 9633842
[TBL] [Abstract][Full Text] [Related]
8. Androgen mediation of thrombocytosis in epithelial ovarian cancer biology.
Li AJ; Karlan BY
Clin Cancer Res; 2005 Nov; 11(22):8015-8. PubMed ID: 16299230
[TBL] [Abstract][Full Text] [Related]
9. Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology.
Li AJ; Elmore RG; Pavelka JC; Karlan BY
Gynecol Oncol; 2007 Dec; 107(3):420-3. PubMed ID: 17825390
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
Li AJ; Scoles DR; Armstrong KU; Karlan BY
Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
[TBL] [Abstract][Full Text] [Related]
11. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
Li AJ; McAllister P; Karlan BY
Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
[TBL] [Abstract][Full Text] [Related]
13. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.
Li AJ; Baldwin RL; Karlan BY
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3667-73. PubMed ID: 14506156
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
